EWTX Edgewise Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $5.0B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $2.0M | $1.2M |
| 2022-Q3 | $15.0M | $214.8K |
| 2022-Q4 | $0 | $46.2K |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $116.0K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $101.0K | $1.7M |
| 2024-Q1 | $10.0M | $2.2M |
| 2024-Q2 | $0 | $269.3K |
| 2024-Q3 | $0 | $9.1M |
| 2024-Q4 | $0 | $3.6M |
| 2025-Q1 | $0 | $1.6M |
| 2025-Q2 | $0 | $262.4K |
| 2025-Q3 | $0 | $1.7M |
| 2025-Q4 | $199.4K | $2.1M |
| 2026-Q1 | $0 | $4.6M |
| 2026-Q2 | $0 | $3.0M |
| 2026-Q3 | $0 | $9.8M |
| 2026-Q4 | $0 | $201.8K |
Bought$27.3M9 buy days
Sold$41.7M84 sell days
Net insider flow-$14.4Mnet selling · 5 years
Latest trade2026-11-10Nofi Michael
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Nofi Michael | CFO | 4,442 | $45.43 | $201.8K | 1 |
| 2026-08-13 | Sell | Donovan Joanne M. | Other C-suite | 2,919 | $43.41 | $126.7K | 1 |
| 2026-08-12 | Sell | KOCH KEVIN | CEO | 17,971 | $43.68 | $785.0K | 3 |
| 2026-08-12 | Sell | Donovan Joanne M. | Other C-suite | 6,522 | $43.85 | $286.0K | 4 |
| 2026-08-12 | Sell | Russell Alan J | Other C-suite | 5,901 | $43.73 | $258.0K | 3 |
| 2026-08-12 | Sell | Derakhshan Behrad | Other C-suite | 5,100 | $43.81 | $223.4K | 4 |
| 2026-08-12 | Sell | MOORE JOHN R | General counsel | 5,016 | $43.82 | $219.8K | 4 |
| 2026-07-01 | Sell | Russell Alan J | Other C-suite | 200,000 | $39.41 | $7.9M | 2 |
| 2026-05-05 | Sell | Donovan Joanne M. | Other C-suite | 50,000 | $38.57 | $1.9M | 1 |
| 2026-05-04 | Sell | Donovan Joanne M. | Other C-suite | 5,230 | $31.29 | $163.6K | 1 |
| 2026-04-01 | Sell | Donovan Joanne M. | Other C-suite | 28,662 | $32.31 | $926.1K | 1 |
| 2026-03-31 | Sell | Donovan Joanne M. | Other C-suite | 21,338 | $32.12 | $685.4K | 1 |
| 2026-03-27 | Sell | Donovan Joanne M. | Other C-suite | 16,358 | $30.98 | $506.8K | 2 |
| 2026-01-21 | Sell | Edris Badreddin | Director | 115,471 | $29.44 | $3.4M | 5 |
| 2025-11-12 | Sell | Russell Alan J | Other C-suite | 100,000 | $21.12 | $2.1M | 1 |
| 2025-11-11 | Buy | Fox Jonathan C | Director | 10,700 | $18.64 | $199.4K | 1 |
| 2025-08-26 | Sell | Russell Alan J | Other C-suite | 100,000 | $14.60 | $1.5M | 1 |
| 2025-08-12 | Sell | KOCH KEVIN | CEO | 7,972 | $13.39 | $106.7K | 1 |
| 2025-08-12 | Sell | Donovan Joanne M. | Other C-suite | 2,862 | $13.39 | $38.3K | 1 |
| 2025-08-12 | Sell | Derakhshan Behrad | Other C-suite | 2,491 | $13.39 | $33.4K | 1 |
| 2025-08-12 | Sell | MOORE JOHN R | General counsel | 2,098 | $13.39 | $28.1K | 1 |
| 2025-08-12 | Sell | Russell Alan J | Other C-suite | 1,907 | $13.39 | $25.5K | 1 |
| 2025-08-12 | Sell | Carruthers R Michael | CFO | 1,428 | $13.39 | $19.1K | 1 |
| 2025-05-02 | Sell | Donovan Joanne M. | Other C-suite | 5,187 | $16.45 | $85.3K | 1 |
| 2025-05-02 | Sell | KOCH KEVIN | CEO | 4,276 | $16.45 | $70.3K | 1 |
| 2025-05-02 | Sell | MOORE JOHN R | General counsel | 1,930 | $16.45 | $31.7K | 1 |
| 2025-05-02 | Sell | Derakhshan Behrad | Other C-suite | 1,691 | $16.45 | $27.8K | 1 |
| 2025-05-02 | Sell | Russell Alan J | Other C-suite | 1,551 | $16.45 | $25.5K | 1 |
| 2025-05-02 | Sell | Carruthers R Michael | CFO | 1,314 | $16.45 | $21.6K | 1 |
| 2025-03-07 | Sell | Russell Alan J | Other C-suite | 200 | $30.02 | $6.0K | 1 |
| 2025-03-07 | Sell | KOCH KEVIN | CEO | 100 | $30.00 | $3.0K | 1 |
| 2025-02-06 | Sell | Russell Alan J | Other C-suite | 1,200 | $30.13 | $36.2K | 1 |
| 2025-02-06 | Sell | KOCH KEVIN | CEO | 900 | $31.13 | $28.0K | 1 |
| 2025-02-05 | Sell | Derakhshan Behrad | Other C-suite | 10,000 | $30.03 | $300.3K | 1 |
| 2025-02-05 | Sell | KOCH KEVIN | CEO | 8,636 | $30.03 | $259.3K | 1 |
| 2025-02-05 | Sell | Russell Alan J | Other C-suite | 8,015 | $30.02 | $240.6K | 1 |
| 2025-01-28 | Sell | Donovan Joanne M. | Other C-suite | 25,000 | $27.63 | $690.8K | 1 |
| 2024-12-30 | Sell | Russell Alan J | Other C-suite | 100,000 | $27.37 | $2.7M | 1 |
| 2024-12-24 | Sell | Semigran Marc | Other C-suite | 29,709 | $29.68 | $881.9K | 2 |
| 2024-09-23 | Sell | MOORE JOHN R | General counsel | 20,922 | $27.63 | $578.1K | 1 |
| 2024-09-20 | Sell | Carruthers R Michael | CFO | 125,092 | $28.57 | $3.6M | 4 |
| 2024-09-20 | Sell | Russell Alan J | Other C-suite | 75,000 | $28.26 | $2.1M | 2 |
| 2024-09-20 | Sell | MOORE JOHN R | General counsel | 50,000 | $28.37 | $1.4M | 1 |
| 2024-09-20 | Sell | Derakhshan Behrad | Other C-suite | 42,068 | $29.03 | $1.2M | 1 |
| 2024-09-20 | Sell | Donovan Joanne M. | Other C-suite | 7,162 | $28.29 | $202.6K | 1 |
| 2024-05-02 | Sell | Donovan Joanne M. | Other C-suite | 3,682 | $18.91 | $69.6K | 1 |
| 2024-05-02 | Sell | KOCH KEVIN | CEO | 3,152 | $18.91 | $59.6K | 1 |
| 2024-05-02 | Sell | Carruthers R Michael | CFO | 2,157 | $18.91 | $40.8K | 1 |
| 2024-05-02 | Sell | MOORE JOHN R | General counsel | 1,956 | $18.91 | $37.0K | 1 |
| 2024-05-02 | Sell | Derakhshan Behrad | Other C-suite | 1,718 | $18.91 | $32.5K | 1 |
| 2024-05-02 | Sell | Russell Alan J | Other C-suite | 1,576 | $18.91 | $29.8K | 1 |
| 2024-02-09 | Sell | MOORE JOHN R | General counsel | 8,029 | $20.01 | $160.7K | 1 |
| 2024-02-09 | Sell | Derakhshan Behrad | Other C-suite | 4,800 | $20.04 | $96.2K | 1 |
| 2024-02-08 | Sell | Derakhshan Behrad | Other C-suite | 4,600 | $20.01 | $92.0K | 1 |
| 2024-02-08 | Sell | MOORE JOHN R | General counsel | 3,813 | $20.01 | $76.3K | 1 |
| 2024-02-07 | Sell | MOORE JOHN R | General counsel | 17,993 | $20.00 | $359.9K | 1 |
| 2024-02-07 | Sell | Derakhshan Behrad | Other C-suite | 600 | $20.00 | $12.0K | 1 |
| 2024-01-23 | Buy | Thompson Peter A. | Director | 454,545 | $11.00 | $5.0M | 1 |
| 2024-01-23 | Buy | ORBIMED ADVISORS LLC | Director | 454,545 | $11.00 | $5.0M | 1 |
| 2024-01-23 | Sell | Carruthers R Michael | CFO | 90,000 | $15.78 | $1.4M | 1 |
| 2023-12-27 | Sell | MOORE JOHN R | General counsel | 8,497 | $10.50 | $89.2K | 1 |
| 2023-12-26 | Sell | Russell Alan J | Other C-suite | 172,585 | $9.33 | $1.6M | 1 |
| 2023-12-26 | Buy | Fox Jonathan C | Director | 10,857 | $9.30 | $101.0K | 1 |
| 2023-05-02 | Sell | Donovan Joanne M. | Other C-suite | 3,254 | $8.90 | $29.0K | 1 |
| 2023-05-02 | Sell | KOCH KEVIN | CEO | 3,203 | $8.90 | $28.5K | 1 |
| 2023-05-02 | Sell | MOORE JOHN R | General counsel | 1,897 | $8.90 | $16.9K | 1 |
| 2023-05-02 | Sell | Derakhshan Behrad | Other C-suite | 1,747 | $8.90 | $15.5K | 1 |
| 2023-05-02 | Sell | Russell Alan J | Other C-suite | 1,602 | $8.90 | $14.3K | 1 |
| 2023-05-02 | Sell | Carruthers R Michael | CFO | 1,336 | $8.90 | $11.9K | 1 |
| 2022-10-03 | Sell | MOORE JOHN R | General counsel | 4,730 | $9.76 | $46.2K | 1 |
| 2022-09-16 | Buy | ORBIMED ADVISORS LLC | Director | 484,496 | $10.32 | $5.0M | 1 |
| 2022-09-16 | Buy | Thompson Peter A. | Director | 484,496 | $10.32 | $5.0M | 1 |
| 2022-09-14 | Buy | Novo Holdings A/S | 10% owner | 484,496 | $10.32 | $5.0M | 1 |
| 2022-09-06 | Sell | MOORE JOHN R | General counsel | 4,730 | $10.91 | $51.6K | 2 |
| 2022-08-03 | Sell | MOORE JOHN R | General counsel | 9,232 | $9.31 | $85.9K | 1 |
| 2022-07-06 | Sell | MOORE JOHN R | General counsel | 1,046 | $8.54 | $8.9K | 1 |
| 2022-07-05 | Sell | MOORE JOHN R | General counsel | 8,186 | $8.35 | $68.4K | 1 |
| 2022-06-21 | Sell | MOORE JOHN R | General counsel | 31,078 | $7.29 | $226.6K | 1 |
| 2022-06-17 | Sell | MOORE JOHN R | General counsel | 22,127 | $6.62 | $146.5K | 1 |
| 2022-06-16 | Sell | MOORE JOHN R | General counsel | 14,722 | $6.17 | $90.8K | 1 |
| 2022-06-15 | Sell | MOORE JOHN R | General counsel | 18,660 | $6.11 | $114.0K | 2 |
| 2022-06-14 | Sell | MOORE JOHN R | General counsel | 3,628 | $6.02 | $21.8K | 1 |
| 2022-06-13 | Sell | MOORE JOHN R | General counsel | 4,093 | $6.01 | $24.6K | 1 |
| 2022-06-10 | Sell | MOORE JOHN R | General counsel | 7,125 | $6.05 | $43.1K | 1 |
| 2022-06-09 | Sell | MOORE JOHN R | General counsel | 7,615 | $6.49 | $49.4K | 1 |
| 2022-06-08 | Sell | MOORE JOHN R | General counsel | 12,566 | $6.63 | $83.3K | 1 |
| 2022-06-07 | Sell | MOORE JOHN R | General counsel | 18,123 | $6.61 | $119.8K | 2 |
| 2022-06-06 | Sell | MOORE JOHN R | General counsel | 13,934 | $6.03 | $84.0K | 1 |
| 2022-06-03 | Sell | MOORE JOHN R | General counsel | 15,230 | $6.05 | $92.1K | 1 |
| 2022-05-18 | Buy | Thompson Peter A. | Director | 138,000 | $7.21 | $995.0K | 1 |
| 2022-05-18 | Buy | ORBIMED ADVISORS LLC | Director | 138,000 | $7.21 | $995.0K | 1 |
| 2022-05-16 | Sell | MOORE JOHN R | General counsel | 10,800 | $7.42 | $80.1K | 1 |
| 2021-11-15 | Sell | Russell Alan J | Other C-suite | 479 | $19.11 | $9.2K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Russell Alan J | Other C-suite | $0 | $18.6M | 2026-08-12 |
| ORBIMED ADVISORS LLC | Director | $11.0M | $0 | 2024-01-23 |
| Thompson Peter A. | Director | $11.0M | $0 | 2024-01-23 |
| Donovan Joanne M. | Other C-suite | $0 | $5.7M | 2026-08-13 |
| Carruthers R Michael | CFO | $0 | $5.1M | 2025-08-12 |
| Novo Holdings A/S | 10% owner | $5.0M | $0 | 2022-09-14 |
| MOORE JOHN R | General counsel | $0 | $4.5M | 2026-08-12 |
| Edris Badreddin | Director | $0 | $3.4M | 2026-01-21 |
| Derakhshan Behrad | Other C-suite | $0 | $2.1M | 2026-08-12 |
| KOCH KEVIN | CEO | $0 | $1.3M | 2026-08-12 |
| Semigran Marc | Other C-suite | $0 | $881.9K | 2024-12-24 |
| Fox Jonathan C | Director | $300.4K | $0 | 2025-11-11 |
| Nofi Michael | CFO | $0 | $201.8K | 2026-11-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-12-26 → 2024-01-23 | 3 | $10.1M | 43 | +1.6% (+5.2% raw) | 0.0% (+1.0% raw) | -0.6% (+12.6% raw) | closed |
| 2022-09-14 → 2022-09-16 | 3 | $15.0M | 51 | +2.5% (+1.4% raw) | -18.5% (-19.1% raw) | -28.4% (-27.6% raw) | closed |
| 2021-03-30 | 5 | $31.8M | 49 | -10.4% (-5.4% raw) | -40.5% (-32.1% raw) | -54.2% (-45.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.